ALPHA PARADIGM PARTNERS, LLC Ultragenyx Pharmaceutical Inc. Transaction History

ALPHA PARADIGM PARTNERS, LLC portfolio value:

$279,000
portfolio value

Ultragenyx Pharmaceutical Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 6.74K shares 279K $41.41 6.74K
Q2 2022 share Decrease -100.00% -6.80K shares -494K $59.66 0
Q1 2022 share Increase +407.15% 5.46K shares 381K $72.62 6.80K
Q4 2021 share Increase 0.00% 1.34K shares 113K $84.25 1.34K